Turnstone Biologics is engaged in the development of medicines to treat and cure patients with solid tumors. Co. is developing a differentiated approach to tumor infiltrating lymphocyte (TIL) therapies by selecting the potent, which able to mediate an anti-tumor response and tumor-reactive T cells. Co. has initiated two Phase 1 clinical trials for its Selected TIL product candidate, TIDAL-01, for the treatment of breast cancer, colorectal cancer, uveal melanoma and other non-cutaneous and cutaneous melanomas. Co. also advances on its preclinical pipeline programs including TIDAL-02, next Selected TIL program and TIDAL-01 viral immunotherapy combination program. We show 4 historical shares outstanding datapoints in our TSBX shares outstanding history coverage, used to compute TSBX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing TSBX market cap history over the course of time is important for investors
interested in comparing TSBX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of TSBX versus a peer is one thing; comparing
TSBX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like TSBX can fluctuate over the course of history.
With this page we aim to empower investors researching TSBX by allowing them to research the TSBX market cap history. |
Free TSBX Email Alerts:
Video: The Importance of Market Cap
